Zoster eye disease study (ZEDS):
A multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthamicus (HZO) in the year prior to enrollment. (Protocol# 16-00463),
Role: Investigator,
National Eye Institute/NIH/DHHS,
(03/2018 - 07/2024)
Status: Completed
For Profit Organization
A PHASE 3, MULTI-CENTER, RANDOMIZED, PARALLEL, DOUBLE MASKED, PLACEBO-CONTROLLED CLINICAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF 0.1 % RGN-259 OPHTHALMIC SOLUTION FOR THE TREATMENT OF NEUROTROPHIC KERATOPATHY (SEER-2),
Role: PI,
ReGen Tree, LLC,
(08/2024 - 08/2025)
Status: Approved
Study to Evaluate the Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants with Persistent Corneal Epithelial Defect (PCED),
Role: PI,
Combangio, Inc.,
(03/2025 - 03/2026)
Status: Approved
CSB-C20-003: A Multi-Center. Randomized, Double-Masked, Vehicle-Controlled. Parallel-Group. Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1 % in stage 2 and 3 Neurotrophic Keratitis Subjects,
Role: PI,
Claris Biotherapeutics,
(11/2023 - 09/2024)
Status: Completed
Internal
Retrospective Analysis of Incidence, Prevalence, and Treatment Modalities of Neurotrophic Keratitis Post-Retinal Procedures,
Role: Investigator,
LLU Dept. of Ophthalmology,
(08/2023)
Status: Approved
The effects of call on dry eye symptoms as measured by the Schirmer Test,
Role: PI,
LLU Dept. of Ophthalmology,
(07/2013 - 07/2014)
Status: Completed